InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Sukhtian Ghiath M., Director. Director active across 1 company, notably Outlook Therapeutics, Inc.. Aggregated, 4 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €35.4m. History available since 29 November 2021. The latest transaction was disclosed on 1 February 2022 (J). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
2,500,000 shares@ US$1.2510.09% mcap6.8% of flowCommon StockSEC:0000947871-22-000124:0
2,500,000 shares@ US$1.2510.09% mcap13.6% of flowCommon StockSEC:0000947871-22-000124
16,000,000 shares@ US$1.2564.24% mcap43.2% of flowCommon StockSEC:0000947871-21-001250:0
Ideal exit: 26 Aug 2022 (T+270)
16,000,000 shares@ US$1.2564.24% mcap86.4% of flowCommon StockSEC:0000947871-21-001250
Ideal exit: 26 Aug 2022 (T+270)
4 of 4 declarations
About Sukhtian Ghiath M.
Ghiath M. Sukhtian is a Director at Outlook Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. His experience is valuable for the development of Outlook Therapeutics.
